oa Epidemiology of herpes zoster in the State of Qatar, 2012–2017

References

1. Yawn B, Gilden D. The global epidemiology of herpes zoster. Neurology. 2013; 81:10:928–930.
   [Google Scholar]
2. Mueller N, Gilden D, Cohrs R, Mahalingam R, Nagel M. Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol Clin. 2008; 26:3:675–697.
   [Google Scholar]
3. Al-Turab M, Chehadeh W. Varicella infection in the Middle East: prevalence, complications, and vaccination. J Res Med Sci. 2018; 23::19.
   [Google Scholar]
4. Kawai K, Gebremeskel B, Acosta C. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014; 4:6:e004833.
   [Google Scholar]
5. Fields B, Knipe D, Howley P. Fields virology. 6th Ed. Philadelphia: Wolters Kluwer; Lippincott Williams & Wilkins 2013.
6. Panatto D, Bragazzi N, Rizzitelli E, Bonanni P, Boccalini S, Icardi G, et al.  Evaluation of the economic burden of Herpes Zoster (HZ) infection. Hum Vaccin Immunother. 2015; 11:1:245–262.
   [Google Scholar]
7. Wehrhahn M, Dwyer D. Herpes zoster: epidemiology, clinical features, treatment and prevention. Aust Prescr. 2012; 35:5:143–147.
   [Google Scholar]
8. Alakloby O, Al Jabre S, Randhawa M, Alzahrani A, Al Wunais K, Bukhari I. Herpes zoster in eastern Saudi Arabia: clinical presentation and management. J Drugs Dermatol. 2008; 7:5:457–462.
   [Google Scholar]
9. Al-Shami M. Herpes zoster in Al-Kuwait university hospital in Sana'a city Yemen: clinical presentation and complications. Alandalus Journal for Social and Applied Sciences. 2014; 6::17–38.
   [Google Scholar]
10. Babamahmoodi F, Alikhani A, Ahangarkani F, Delavarian L, Barani H, Babamahmoodi A. Clinical manifestations of herpes zoster, its comorbidities, and its complications in North of Iran from 2007 to 2013. Neurol Res Int. 2015; 2015::896098.
    [Google Scholar]
11. Kawai K, Yawn B. Risk factors for herpes zoster: a systematic review and meta-analysis. Open Forum Infect Dis. 2017; 4:1:S313–S314.
    [Google Scholar]
12. Chehab M, Bala M, Al-Dahshan A. Travel medicine in Qatar: strategic action for better public health outcome. Int J Travel Med Glob Health. 2018; 6:3:137–138.
    [Google Scholar]
13. Lu W, Lin C, Wang C, Chen L, Hsiao F. Epidemiology and long-term disease burden of herpes zoster and postherpetic neuralgia in Taiwan: a population-based, propensity score-matched cohort study. BMC Public Health. 2018; 18:1:369.
    [Google Scholar]
14. Marziano V, Poletti P, Guzzetta G, Ajelli M, Manfredi P, Merler S. The impact of demographic changes on the epidemiology of herpes zoster: Spain as a case study. Proc Biol Sci. 2015; 282:1804:20142509.
    [Google Scholar]
15. Zhu Q, Zheng H, Qu H, Deng H, Zhang J, Ma W, et al.  Epidemiology of herpes zoster among adults aged 50 and above in Guangdong. China. Hum Vaccin Immunother. 2015; 11:8:2113–2118.
    [Google Scholar]
16. Gershon A, Gershon M, Breuer J, Levin M, Oaklander A, Griffiths P. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol. 2010; 48:1:S2–S7.
    [Google Scholar]
17. Kim Y, Lee C, Lim C, Jeon W, Park Y. Population-based study of the epidemiology of herpes zoster in Korea. J Korean Med Sci. 2014; 29:12:1706–1710.
    [Google Scholar]
18. Rahman M, Karim M, Tauhid S, Das A, Sarkar S. Is there any seasonal influence of herpes zoster? Faridpur Med Coll J. 2017; 12:1:14–17.
    [Google Scholar]
19. Wu P, Wu H, Chou T, Sung F. Varicella vaccination alters the chronological trends of herpes zoster and varicella. PLoS One. 2013; 8:10:e77709.
    [Google Scholar]
20. Zak-Prelich M, Borkowski J, Alexander F, Norval M. The role of solar ultraviolet irradiation in zoster. Epidemiol Infect. 2002; 129:3:593–597.
    [Google Scholar]
21. Di-Pietro A, Facciolà A, Visalli G. Herpes zoster vaccine: a protection for the elderly. Ann Ig. 2018; 30:4:23–27.
    [Google Scholar]